FFA
ALT icon

Farther Finance Advisors’s Altimmune ALT Stock Holding History

Farther Finance Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.41K Sell
843
-201
-19% -$617 ﹤0.01% 5333
2026
Q2 		$3.16K Buy
1,044
+903
+640% +$2.7K ﹤0.01% 5004
2026
Q1 		$440 Buy
141
+68
+93% +$289 ﹤0.01% 5297
2025
Q4 		$264 Hold
73
– – ﹤0.01% 5163
2025
Q3 		$275 Buy
73
+54
+284% +$208 ﹤0.01% 4657
2025
Q2 		$74 Hold
19
– – ﹤0.01% 4339
2025
Q1 		$90 Hold
19
– – ﹤0.01% 4077
2024
Q4 		$137 Hold
19
– – ﹤0.01% 3731
2024
Q3 		$117 Hold
19
– – ﹤0.01% 3754
2024
Q2 		$137 Sell
19
-77
-80% -$568 ﹤0.01% 3554
2024
Q1 		$982 Buy
96
+77
+405% +$783 ﹤0.01% 2781
2023
Q4 		$214 Buy
+19
New +$79 ﹤0.01% 3214

Other funds holding ALT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
MWP
Meriwether Wealth & Planning Minden, Louisiana $222M AUM 15.77% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Farther Finance Advisors's ALT Position: Q3 2026 in Review

Farther Finance Advisors reduced its Altimmune (ALT) stake by 19% in Q3 2026, selling an estimated $617 and leaving 843 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #5333.

Farther Finance Advisors first reported a position in ALT in Q4 2023 and has held it in 12 quarters since. The position peaked at $3.16K in Q2 2026. 7 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Farther Finance Advisors held 843 shares of Altimmune worth $2.41K as of Q3 2026.
  • Farther Finance Advisors sold 201 Altimmune shares in Q3 2026, an estimated $617.
  • Altimmune made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5333 holding.
  • Farther Finance Advisors first reported a position in Altimmune in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Altimmune position peaked at $3.16K in Q2 2026.
  • 7 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.